Academic publications - Lane Clark & Peacock LLP

Services Health services Services
With our innovative and market leading analytics, we aim to lead the transition of health systems from importers of illness to exporters of health by realigning value between patients, manufacturers of medicines and payers.
Learn more Real world evidence generation Health economics outcomes research Market access and evidence generation strategy Medical and public affairs
Focus areas Focus areas Focus areas

We work with clients to navigate complex issues across the entire innovation lifecycle, leveraging our expertise across services to deliver comprehensive solutions.

Learn more Health equity Obesity
Our experts
Insights
Technology
Explore LCP
- LCP Home
- What we do
- About us
- Media centre
- Insights
- Our experts
- Events
- Let's talk

Let's talk

Home
Health
Insights
Academic publications

Academic publications

An insurance value modeling approach that captures the wider value of a novel antimicrobial to health systems, patients, and the population

Read on the Journal of Health Economics and Outcomes Research

Value-Based Healthcare in practice: IDEATE, a collaboration to design and test an outcomes-based agreement for a medicine in Wales

Read on Research Square

Emulating trials and quantifying bias: The convergence of health technology assessment agency real-world evidence guidance

Read on Value in Health

Real world outcomes, healthcare utilisation and costs of Alzheimer's disease in England

Read on ScienceDirect

Is the price right? Paying for value today to get more value tomorrow

Read on BMC Medicine

Health Technology Assessment in the US — A word of caution

Read on JAMA Internal Medicine

Does industry really develop less medicines with clinical benefit?

Read on JAMA Internal Medicine

Access in all areas? A round up of developments in market access and health technology assessment

Read Part 3 Read Part 4

EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?

Read on Becaris

First in class, best in class or a wild card: who will dominate the anti-obesity medication market?

Read on Becaris

Why is target trial emulation not being used in health technology assessment real-world data submissions?

Read on Becaris

Tackling health inequalities through the development of the wider public health workforce